Literature DB >> 21957147

HIV-1 N-glycan composition governs a balance between dendritic cell-mediated viral transmission and antigen presentation.

Thijs van Montfort1, Dirk Eggink, Maikel Boot, Michael Tuen, Catarina E Hioe, Ben Berkhout, Rogier W Sanders.   

Abstract

The natural function of dendritic cells (DCs) is to capture and degrade pathogens for Ag presentation. However, HIV-1 can evade viral degradation by DCs and hijack DCs for migration to susceptible CD4(+) T lymphocytes. It is unknown what factors decide whether a virus is degraded or transmitted to T cells. The interaction of DCs with HIV-1 involves C-type lectin receptors, such as DC-specific ICAM-3-grabbing nonintegrin, which bind to the envelope glycoprotein complex (Env), which is decorated heavily with N-linked glycans. We hypothesized that the saccharide composition of the Env N-glycans is involved in avoiding viral degradation and Ag presentation, as well as preserving infectious virus for the transmission to target cells. Therefore, we studied the fate of normally glycosylated virus versus oligomannose-enriched virus in DCs. Changing the heterogeneous N-linked glycan composition of Env to uniform oligomannose N-glycans increased the affinity of HIV-1 for DC-specific ICAM-3-grabbing nonintegrin and enhanced the capture of HIV-1 by immature DCs; however, it decreased the subsequent transmission to target cells. Oligomannose-enriched HIV-1 was directed more efficiently into the endocytic pathway, resulting in enhanced viral degradation and reduced virus transfer to target cells. Furthermore, Env containing exclusively oligomannose N-glycans was presented to Env-specific CD4(+) T cells more efficiently. Taken together, our results showed that the HIV-1 N-glycan composition plays a crucial role in the balance between DC-mediated Ag degradation and presentation and DC-mediated virus transmission to target cells. This finding may have implications for the early events in HIV-1 transmission and the induction of antiviral immune responses.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21957147      PMCID: PMC3590799          DOI: 10.4049/jimmunol.1101876

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  62 in total

1.  DC-SIGN mediates adhesion and rolling of dendritic cells on primary human umbilical vein endothelial cells through LewisY antigen expressed on ICAM-2.

Authors:  Juan J García-Vallejo; Ellis van Liempt; Paula da Costa Martins; Cora Beckers; Bert van het Hof; Sonja I Gringhuis; Jaap-Jan Zwaginga; Willem van Dijk; Teunis B H Geijtenbeek; Yvette van Kooyk; Irma van Die
Journal:  Mol Immunol       Date:  2007-12-26       Impact factor: 4.407

2.  HIV-1 replication in dendritic cells occurs through a tetraspanin-containing compartment enriched in AP-3.

Authors:  Eduardo Garcia; Damjan S Nikolic; Vincent Piguet
Journal:  Traffic       Date:  2007-11-22       Impact factor: 6.215

3.  Dendritic cells preferentially transfer CXCR4-using human immunodeficiency virus type 1 variants to CD4+ T lymphocytes in trans.

Authors:  Thijs van Montfort; Adri A M Thomas; Georgios Pollakis; William A Paxton
Journal:  J Virol       Date:  2008-06-04       Impact factor: 5.103

4.  Functionally distinct transmission of human immunodeficiency virus type 1 mediated by immature and mature dendritic cells.

Authors:  Jian-Hua Wang; Alicia M Janas; Wendy J Olson; Li Wu
Journal:  J Virol       Date:  2007-06-13       Impact factor: 5.103

5.  The C-type lectin surface receptor DCIR acts as a new attachment factor for HIV-1 in dendritic cells and contributes to trans- and cis-infection pathways.

Authors:  Alexandra A Lambert; Caroline Gilbert; Manon Richard; André D Beaulieu; Michel J Tremblay
Journal:  Blood       Date:  2008-06-09       Impact factor: 22.113

6.  Capture and transfer of HIV-1 particles by mature dendritic cells converges with the exosome-dissemination pathway.

Authors:  Nuria Izquierdo-Useros; Mar Naranjo-Gómez; Jacob Archer; Steven C Hatch; Itziar Erkizia; Julià Blanco; Francesc E Borràs; Maria Carmen Puertas; John H Connor; Maria Teresa Fernández-Figueras; Landon Moore; Bonaventura Clotet; Suryaram Gummuluru; Javier Martinez-Picado
Journal:  Blood       Date:  2008-10-22       Impact factor: 22.113

7.  Enzymatic removal of mannose moieties can increase the immune response to HIV-1 gp120 in vivo.

Authors:  Kaustuv Banerjee; Sofija Andjelic; Per Johan Klasse; Yun Kang; Rogier W Sanders; Elizabeth Michael; Robert J Durso; Thomas J Ketas; William C Olson; John P Moore
Journal:  Virology       Date:  2009-05-02       Impact factor: 3.616

8.  Targeting DCIR on human plasmacytoid dendritic cells results in antigen presentation and inhibits IFN-alpha production.

Authors:  Friederike Meyer-Wentrup; Daniel Benitez-Ribas; Paul J Tacken; Cornelis J A Punt; Carl G Figdor; I Jolanda M de Vries; Gosse J Adema
Journal:  Blood       Date:  2008-02-07       Impact factor: 22.113

9.  HIV-1 gp120 mannoses induce immunosuppressive responses from dendritic cells.

Authors:  Meimei Shan; Per Johan Klasse; Kaustuv Banerjee; Antu K Dey; Sai Prasad N Iyer; Robert Dionisio; Dustin Charles; Lila Campbell-Gardener; William C Olson; Rogier W Sanders; John P Moore
Journal:  PLoS Pathog       Date:  2007-11       Impact factor: 6.823

10.  The carbohydrate at asparagine 386 on HIV-1 gp120 is not essential for protein folding and function but is involved in immune evasion.

Authors:  Rogier W Sanders; Eelco van Anken; Alexei A Nabatov; I Marije Liscaljet; Ilja Bontjer; Dirk Eggink; Mark Melchers; Els Busser; Martijn M Dankers; Fedde Groot; Ineke Braakman; Ben Berkhout; William A Paxton
Journal:  Retrovirology       Date:  2008-01-31       Impact factor: 4.602

View more
  25 in total

Review 1.  Recent strategies targeting HIV glycans in vaccine design.

Authors:  Satoru Horiya; Iain S MacPherson; Isaac J Krauss
Journal:  Nat Chem Biol       Date:  2014-12       Impact factor: 15.040

2.  Elicitation of broadly reactive antibodies against glycan-modulated neutralizing V3 epitopes of HIV-1 by immune complex vaccines.

Authors:  Rajnish Kumar; Michael Tuen; Jianping Liu; Arthur Nàdas; Ruimin Pan; Xiangpeng Kong; Catarina E Hioe
Journal:  Vaccine       Date:  2013-09-16       Impact factor: 3.641

Review 3.  Cellular and viral mechanisms of HIV-1 transmission mediated by dendritic cells.

Authors:  Christopher M Coleman; Corine St Gelais; Li Wu
Journal:  Adv Exp Med Biol       Date:  2013       Impact factor: 2.622

4.  HIV-1 envelope glycan moieties modulate HIV-1 transmission.

Authors:  Ruizhong Shen; Milan Raska; Diane Bimczok; Jan Novak; Phillip D Smith
Journal:  J Virol       Date:  2014-10-01       Impact factor: 5.103

5.  Metabolic labeling of HIV-1 envelope glycoprotein gp120 to elucidate the effect of gp120 glycosylation on antigen uptake.

Authors:  Lina Sun; Mayumi Ishihara; Dustin R Middleton; Michael Tiemeyer; Fikri Y Avci
Journal:  J Biol Chem       Date:  2018-08-16       Impact factor: 5.157

6.  Asparagine-Linked Glycans of Cryptosporidium parvum Contain a Single Long Arm, Are Barely Processed in the Endoplasmic Reticulum (ER) or Golgi, and Show a Strong Bias for Sites with Threonine.

Authors:  John R Haserick; Deborah R Leon; John Samuelson; Catherine E Costello
Journal:  Mol Cell Proteomics       Date:  2017-02-08       Impact factor: 5.911

7.  Structural basis for diverse N-glycan recognition by HIV-1-neutralizing V1-V2-directed antibody PG16.

Authors:  Marie Pancera; Syed Shahzad-Ul-Hussan; Nicole A Doria-Rose; Jason S McLellan; Robert T Bailer; Kaifan Dai; Sandra Loesgen; Mark K Louder; Ryan P Staupe; Yongping Yang; Baoshan Zhang; Robert Parks; Joshua Eudailey; Krissey E Lloyd; Julie Blinn; S Munir Alam; Barton F Haynes; Mohammed N Amin; Lai-Xi Wang; Dennis R Burton; Wayne C Koff; Gary J Nabel; John R Mascola; Carole A Bewley; Peter D Kwong
Journal:  Nat Struct Mol Biol       Date:  2013-05-26       Impact factor: 15.369

Review 8.  Dendritic cells in progression and pathology of HIV infection.

Authors:  Olivier Manches; Davor Frleta; Nina Bhardwaj
Journal:  Trends Immunol       Date:  2013-11-15       Impact factor: 16.687

Review 9.  Aberrant glycosylation and cancer biomarker discovery: a promising and thorny journey.

Authors:  Mengmeng Wang; Jianhui Zhu; David M Lubman; Chunfang Gao
Journal:  Clin Chem Lab Med       Date:  2019-03-26       Impact factor: 8.490

10.  Exclusive Decoration of Simian Immunodeficiency Virus Env with High-Mannose Type N-Glycans Is Not Compatible with Mucosal Transmission in Rhesus Macaques.

Authors:  Christina B Karsten; Falk F R Buettner; Samanta Cajic; Inga Nehlmeier; Berit Neumann; Antonina Klippert; Ulrike Sauermann; Udo Reichl; Rita Gerardy-Schahn; Erdmann Rapp; Christiane Stahl-Hennig; Stefan Pöhlmann
Journal:  J Virol       Date:  2015-09-09       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.